Collagen Solutions PLC Appointment of Chief Financial Officer (2585Z)
14 December 2017 - 6:01PM
UK Regulatory
TIDMCOS
RNS Number : 2585Z
Collagen Solutions PLC
14 December 2017
Collagen Solutions Plc
(the "Company" or the "Group")
Appointment of Chief Financial Officer
Collagen Solutions plc (AIM: COS), a global supplier, developer
and manufacturer of medical grade collagen and tissue components
for use in regenerative medicine applications including
orthopaedics, dental, wounds, and cardiovascular, is pleased to
confirm the appointment of Hilary Spence as Chief Financial Officer
("CFO") as from 3 January 2018, based in our Glasgow office. Hilary
will also join the Board at that time. Hilary takes over from Gill
Black who has decided to step down as CFO and from the Board for
family reasons. Gill will remain with the Company, maintain her
role as Company Secretary and will assist Hilary in the smooth
transition of roles.
Hilary has over 30 years' commercial experience in finance
across a number of multi-sector businesses. Over her career Hilary
has been involved in a number of successful business
transformations where her diverse skills have been used to create,
financially evaluate and implement growth strategies. Hilary has
worked with a broad range of companies from large corporates
including Heineken, Vodafone, Motorola and Premier Foods and
smaller more entrepreneurial businesses. Most recently Hilary was
Interim CFO at the private equity funded Powerleague, where she was
integral to the restructuring and transformation of the finance
systems.
Hilary is a Chartered Accountant, member of ICAS and has a BA in
Business Economics and MBA from Strathclyde University.
Commenting on the appointment, Jamal Rushdy, CEO of Collagen
Solutions said: "Hilary has a wealth of experience both
commercially and financially, working with businesses that mirror
Collagen Solutions growth model and we believe she will be an
important asset to the business in this exciting period of
transitional growth for the Company.
"I would also like to take this opportunity to thank Gill Black
for her hard work over the last three and a half years as CFO. We
are fortunate that she will be staying on within the finance team
in Glasgow and assisting Hilary, particularly in the first few
months of Hilary's induction within the business."
This announcement contains inside information for the purposes
of Article 7 of Regulation (EU) 596/2014.
The following information is disclosed pursuant to Rule 17 and
Schedule Two paragraph (g) of the AIM Rules for Companies in
relation to Hilary Spence.
Current Directorships Previous Directorships
--------------------------- ----------------------------------
Giraff Limited Craigholme School (Non Exec Board
School Leaver Network Ltd member)
Flying Pig Interim Management
Limited
--------------------------- ----------------------------------
Hilary Spence holds no ordinary shares in the capital of the
Company.
Save as disclosed above there are no additional disclosures to
be made in accordance with Rule 17 or Schedule Two paragraph (g) of
the AIM Rules for Companies.
Enquiries:
Collagen Solutions Plc Via Lisa Baderoon
Jamal Rushdy, Chief Executive Officer
Head of Investor Relations Mob: 07721 413 496
Lisa Baderoon (lisa.baderoon@collagensolutions.com)
Cenkos Securities plc (Nominated Tel: 020 7397 8900
Adviser and Broker)
Stephen Keys
Steve Cox
Walbrook PR Tel: 020 7933 8780 or collagen@walbrookpr.com
Mike Wort Mob: 07900 608 002
Anna Dunphy Mob: 07876 741 001
About Collagen Solutions:
Collagen Solutions Plc is a global provider of medical grade
collagen formulations and components for use in regenerative
medicine, medical devices and in-vitro diagnostics and research.
The capabilities of the Company include the provision of native,
soluble and powdered collagen formulations, processed and
semi-processed tissues such as pericardium, bone, and blood
vessels, and expertise in the development and contract manufacture
of collagen components for use as engineered tissue scaffolds and
other medical devices. These products are used in a wide variety of
applications including orthopaedics, cardiovascular, dental,
plastic surgery, wound healing, neurology and urology. Collagen
Solutions' unique offering extends beyond material supply and
contract services through the highly skilled staff who support
customers through the various stages of development and regulatory
approval. For additional information, please visit
www.collagensolutions.com.
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOALLFSVFFLVLID
(END) Dow Jones Newswires
December 14, 2017 02:01 ET (07:01 GMT)
Collagen Solutions (LSE:COS)
Historical Stock Chart
From Apr 2024 to May 2024
Collagen Solutions (LSE:COS)
Historical Stock Chart
From May 2023 to May 2024